Stable biocompatible magnetic nanoparticles have demonstrated their potential in targeting biologically active molecules - including hormones, allergens, and various peptides - to specific cells or tissues expressing their cognate receptors, and may represent versatile and non-invasive tools for monitoring cellular functions both in vitro and in vivo. In this study, betalactoglobulin, one of the major whey proteins and food allergens, was covalently conjugated to biocompatible dextran-coated magnetic nanoparticles. The conjugated protein retained its structure and immunoreactivity towards monoclonal and polyclonal antibodies. BLG-conjugated nanoparticles were taken up by human monocytes much more efficiently than non-conjugated particles, allowing easy magnetic separation of cells that had adsorbed the allergen. To verify whether this approach could be complemented with others for improving our current understanding of the intracellular and intratissutal path of food allergens, BLG was conjugated to magnetic nanoparticles also labeled with a fluorescent probe. The uptake of these materials by human monocytes was monitored through flow cytometry and confocal microscopy, in comparison with fluorescent nanoparticles devoid of the allergen or conjugated with human serum albumin. Both approaches confirm a higher uptake of the BLG-conjugated particles, and confocal microscopy provided direct evidence of actual internalization of the particles into the cytoplasm. These results open up the possibility to use a combination of these approaches for monitoring the fate of food allergens in cells that may be involved in the immune response to food.

Recognition and uptake of nanoparticle-conjugated food allergens by human monocytes / M. Marengo, M. Miriani, F. Bonomi, S. Iametti, E. Prinz, R. Hempelmann, H. Frøkiær. ((Intervento presentato al 36. convegno FEBS Congress - Biochemistry for Tomorrow's Medicine tenutosi a Torino nel 2011.

Recognition and uptake of nanoparticle-conjugated food allergens by human monocytes

M. Marengo
Primo
;
M. Miriani
Secondo
;
F. Bonomi;S. Iametti;
2011

Abstract

Stable biocompatible magnetic nanoparticles have demonstrated their potential in targeting biologically active molecules - including hormones, allergens, and various peptides - to specific cells or tissues expressing their cognate receptors, and may represent versatile and non-invasive tools for monitoring cellular functions both in vitro and in vivo. In this study, betalactoglobulin, one of the major whey proteins and food allergens, was covalently conjugated to biocompatible dextran-coated magnetic nanoparticles. The conjugated protein retained its structure and immunoreactivity towards monoclonal and polyclonal antibodies. BLG-conjugated nanoparticles were taken up by human monocytes much more efficiently than non-conjugated particles, allowing easy magnetic separation of cells that had adsorbed the allergen. To verify whether this approach could be complemented with others for improving our current understanding of the intracellular and intratissutal path of food allergens, BLG was conjugated to magnetic nanoparticles also labeled with a fluorescent probe. The uptake of these materials by human monocytes was monitored through flow cytometry and confocal microscopy, in comparison with fluorescent nanoparticles devoid of the allergen or conjugated with human serum albumin. Both approaches confirm a higher uptake of the BLG-conjugated particles, and confocal microscopy provided direct evidence of actual internalization of the particles into the cytoplasm. These results open up the possibility to use a combination of these approaches for monitoring the fate of food allergens in cells that may be involved in the immune response to food.
giu-2011
allergens ; nanobiotech ; monocytes
Settore BIO/10 - Biochimica
Recognition and uptake of nanoparticle-conjugated food allergens by human monocytes / M. Marengo, M. Miriani, F. Bonomi, S. Iametti, E. Prinz, R. Hempelmann, H. Frøkiær. ((Intervento presentato al 36. convegno FEBS Congress - Biochemistry for Tomorrow's Medicine tenutosi a Torino nel 2011.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/159614
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact